Boston Scientific Corp.'s Therasphere Y-90 glass microspheres received a PMA for treatment of patients with unresectable hepatocellular carcinoma (HCC). The radioembolization technique has been used in more than 70,000 patients under a humanitarian device exemption over the last 20 years. The U.K.'s NICE also recently recommended Therasphere for treatment of patients with HCC.
Keeping you up to date on recent developments in neurology, including: Using AI to track facial changes due to Parkinson’s; Dopamine plays role in pain perception sex differences; Lipid dysregulation gives information on Parkinson’s.
Researchers at the University of California at San Diego have used a gene therapy approach to treat pain by specifically suppressing the Nav 1.7 ion channel in the spinal cord, both preventing and reversing pain in several animal models with distinct underlying reasons for pain.
Keeping you up to date on recent developments in diagnostics, including: Data flaws sink current AI models for COVID-19 diagnosis; Smartphone-based gaze may provide a scalable, digital biomarker of mental fatigue; AI developed to predict disease based on genetic mutations; High blood fats, sugars alter antigen processing.
Keeping you up to date on recent developments in oncology, including: Rethinking dose fractionation in radiotherapy for prostate cancer; Immune system, treatment, in kidney cancer; Targeting membrane protein starves pancreatic tumors; Olive oil, not just for pasta anymore.
